Pulmonary function tests (PFTs) are integral to the diagnosis, management, and monitoring of respiratory diseases. However, interpreting these results can often be complex and challenging. This guide aims to simplify the process and enhance understanding among healthcare professionals.
Primarily, PFTs are composed of spirometry, lung volumes, and diffusing capacity. Spirometry measures the air that can be exhaled or inhaled forcefully and quickly, providing information about airflow obstruction. Lung volumes assess the total amount of air lungs can hold, while diffusing capacity evaluates how well oxygen moves from the lungs to the bloodstream.
The key values in spirometry are Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and their ratio (FEV1/FVC). Normal values are age, sex, and height-dependent. A reduced FEV1/FVC ratio indicates airflow obstruction, commonly seen in conditions like asthma or COPD.
Increased lung volumes suggest air trapping or hyperinflation, often seen in obstructive diseases. Reduced volumes can indicate restrictive lung disease. A decreased diffusing capacity can signify interstitial lung disease or emphysema, while an increased value may be seen in asthma or polycythemia.
Recognizing patterns in PFT results is crucial. Obstructive pattern is characterized by reduced FEV1/FVC ratio with normal or increased lung volumes. A restrictive pattern shows reduced lung volumes with a normal or increased FEV1/FVC ratio. A mixed pattern demonstrates features of both.
Decoding PFT results is a skill that improves with practice. Understanding the components of PFTs and recognizing patterns can help healthcare professionals make accurate diagnoses and guide treatment. Continuous learning and experience are essential in mastering this important aspect of respiratory medicine.
1.
Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women
2.
Chronic pain and poor sleep are troublesome bed partners.
3.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
4.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
5.
New study elucidates obesity's role in fueling breast cancer progression
1.
A Closer Look at MCV Modules: Features, Functions, and Benefits
2.
Minimal Residual Disease Monitoring: Advances, Clinical Relevance, and Guideline-Based Perspectives
3.
Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making
4.
The Role of Calcium Corrections in Accurate Blood Test Results
5.
Oncology Drug Handling Near-Misses: Clinical Risks, Pathophysiology, and Guideline-Based Approaches
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Future of Hematology
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part V
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation